CEO of Axol Bioscience, enabling “Better Human Disease Models” with iPSC technology in neurodegenerative, eye, cardiac, pain and skin disease
5 Key Takeaways from The MPS (Microphysiological Systems) World Summit 2023 From complex co-culture and organoids to microfluidics devices and microtissues, advanced in vitro platforms have the potential to revolutionize drug discovery. In this short article, we outline their 5 key highlights and takeaways from the Summit: https://hubs.la/Q021Dk-_0 #biotechnology #mpsworldsummit #drugdevelopment #organonchip #biopharma #MPS #research #drugdiscovery
From complex co-culture and organoids to microfluidics devices and microtissues, advanced in vitro platforms have the potential to revolutionize drug discovery. The MPS (Microphysiological Systems) World Summit 2023 kicked off in Berlin, bringing together over 1300 scientists and professionals from all over the world to discuss these tiny, but powerful, drug screening models. Axol CEO, Liam Taylor, and Product Manager, Jan Turner, attended to fly the flag for human iPSCs and how we're developing consistent, human-relevant cells at scale to fuel these advanced platforms. In this short article, we outline their 5 key highlights and takeaways from the Summit: https://hubs.la/Q021Dk-_0 Want to discuss how we can supply your MPS/microfluidics devices with consistent, high-quality iPSCs? Get in contact here: https://hubs.la/Q021Dkdj0 #iPSCs #organoids #microfluidics #OrganOnAChip #DrugDiscovery